About envveno medical corp - NVNO
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
NVNO At a Glance
enVVeno Medical Corp.
70 Doppler
Irvine, California 92618
| Phone | 1-949-261-2900 | Revenue | 0.00 | |
| Industry | Medical Specialties | Net Income | -19,472,000.00 | |
| Sector | Health Technology | Employees | 33 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
NVNO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 0.271 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 1.024 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | -0.033 |
NVNO Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -590,060.606 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
NVNO Liquidity
| Current Ratio | 13.584 |
| Quick Ratio | 13.584 |
| Cash Ratio | 13.295 |
NVNO Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -52.263 |
| Return on Equity | -56.205 |
| Return on Total Capital | -69.968 |
| Return on Invested Capital | -55.398 |
NVNO Capital Structure
| Total Debt to Total Equity | 2.58 |
| Total Debt to Total Capital | 2.515 |
| Total Debt to Total Assets | 2.368 |
| Long-Term Debt to Equity | 1.143 |
| Long-Term Debt to Total Capital | 1.114 |